cinacalcet has been researched along with furosemide in 7 studies
| Studies (cinacalcet) | Trials (cinacalcet) | Recent Studies (post-2010) (cinacalcet) | Studies (furosemide) | Trials (furosemide) | Recent Studies (post-2010) (furosemide) |
|---|---|---|---|---|---|
| 1,070 | 155 | 627 | 13,631 | 1,358 | 2,486 |
| Protein | Taxonomy | cinacalcet (IC50) | furosemide (IC50) |
|---|---|---|---|
| Corticosteroid 11-beta-dehydrogenase isozyme 1 | Homo sapiens (human) | 3.76 | |
| Corticosteroid 11-beta-dehydrogenase isozyme 1 | Mus musculus (house mouse) | 3.76 | |
| Broad substrate specificity ATP-binding cassette transporter ABCG2 | Homo sapiens (human) | 3.2 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 6 (85.71) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Alameda Hernando, C; Díaz Guardiola, P; Guijarro de Armas, G; Iglesias Bolaños, P; Pavón de Paz, I; Vega Piñero, B | 1 |
| Atchison, DK; Beierwaltes, WH; Ortiz-Capisano, MC | 1 |
| Drake, WM; Hanson, PL; Jones, P; Pittaway, JF; Srirangalingam, U | 1 |
| Anex, C; Bonny, O; Burnier, M; Forni Ogna, V; Maillard, M; Muller, ME; Stoudmann, C; Wuerzner, G; Zweiacker, C | 1 |
| Alon, US; Jafri, S; Manimtim, WM; Sebestyen VanSickle, J; Srivastava, T; Truog, WE | 1 |
| Accadia, M; Capozza, M; Chinellato, I; Di Lorgi, N; Di Mauro, A; Guarnieri, V; Laforgia, N; Mattioli, G; Traggiai, C | 1 |
1 review(s) available for cinacalcet and furosemide
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for cinacalcet and furosemide
| Article | Year |
|---|---|
Furosemide stimulation of parathormone in humans: role of the calcium-sensing receptor and the renin-angiotensin system.
Topics: Adolescent; Adult; Aldosterone; Calcimimetic Agents; Calcium; Cinacalcet; Diuretics; Female; Furosemide; Humans; Male; Middle Aged; Parathyroid Glands; Parathyroid Hormone; Receptors, Calcium-Sensing; Renin; Renin-Angiotensin System; Solute Carrier Family 12, Member 1; Solute Carrier Family 12, Member 2 | 2015 |
5 other study(ies) available for cinacalcet and furosemide
| Article | Year |
|---|---|
[Primary hyperparathyroidism. An alternative to the surgery].
Topics: Adenoma; Aged, 80 and over; Breast Neoplasms; Carcinoma; Carcinoma, Renal Cell; Cinacalcet; Comorbidity; Contraindications; Diphosphonates; Drug Therapy, Combination; Female; Fluid Therapy; Furosemide; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Imidazoles; Kidney Function Tests; Kidney Neoplasms; Naphthalenes; Parathyroid Neoplasms; Parathyroidectomy; Treatment Refusal; Zoledronic Acid | 2009 |
Acute activation of the calcium-sensing receptor inhibits plasma renin activity in vivo.
Topics: Angiotensin I; Animals; Blood Pressure; Calcium; Cinacalcet; Diuretics; Fluorescent Antibody Technique; Furosemide; Immunohistochemistry; Juxtaglomerular Apparatus; Male; Microscopy, Fluorescence; Naphthalenes; Parathyroidectomy; Rats; Rats, Sprague-Dawley; Receptors, Calcium-Sensing; Renin | 2010 |
Renal replacement therapy as a treatment for severe refractory hypercalcemia.
Topics: Adenoma; Adult; Carcinoma; Cinacalcet; Diphosphonates; Drug Resistance; Emergencies; Female; Furosemide; Hemodiafiltration; Hemofiltration; Humans; Hydroxycholecalciferols; Hypercalcemia; Hypoparathyroidism; Leukemia-Lymphoma, Adult T-Cell; Male; Middle Aged; Naphthalenes; Pamidronate; Pancreatitis, Acute Necrotizing; Parathyroid Neoplasms; Parathyroidectomy | 2014 |
Successful Reversal of Furosemide-Induced Secondary Hyperparathyroidism With Cinacalcet.
Topics: Calcimimetic Agents; Calcium; Cinacalcet; Furosemide; Humans; Hyperparathyroidism, Secondary; Infant; Magnetic Resonance Imaging; Male; Parathyroid Hormone | 2017 |
Case report: acute clinical presentation and neonatal management of primary hyperparathyroidism due to a novel CaSR mutation.
Topics: Bone Density Conservation Agents; Calcimimetic Agents; Cinacalcet; Clodronic Acid; Diphosphonates; Female; Fluid Therapy; Furosemide; Genes, Recessive; Homozygote; Humans; Hyperparathyroidism, Primary; Infant, Newborn; Infant, Newborn, Diseases; Mutation; Parathyroidectomy; Receptors, Calcium-Sensing | 2018 |